BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24728301)

  • 1. Downregulation of the CXCR4 receptor inhibits cervical carcinoma metastatic behavior in vitro and in vivo.
    Sekuła M; Miekus K; Majka M
    Int J Oncol; 2014 Jun; 44(6):1853-60. PubMed ID: 24728301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway.
    Yu T; Wu Y; Helman JI; Wen Y; Wang C; Li L
    Mol Cancer Res; 2011 Feb; 9(2):161-72. PubMed ID: 21205837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells.
    Song ZY; Gao ZH; Chu JH; Han XZ; Qu XJ
    Biomed Pharmacother; 2015 Apr; 71():46-52. PubMed ID: 25960214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of VEGF, MMP-9 and metastasis by CXCR4 in a prostate cancer cell line.
    Wang Q; Diao X; Sun J; Chen Z
    Cell Biol Int; 2011 Sep; 35(9):897-904. PubMed ID: 21306303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel biphenyl urea derivate inhibits the invasion of breast cancer through the modulation of CXCR4.
    Zhan Y; Zhang H; Li J; Zhang Y; Zhang J; He L
    J Cell Mol Med; 2015 Jul; 19(7):1614-23. PubMed ID: 25753200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
    Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
    J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-κB signaling in cervical cancer.
    Chang YW; Chen MW; Chiu CF; Hong CC; Cheng CC; Hsiao M; Chen CA; Wei LH; Su JL
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S687-95. PubMed ID: 25047463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of CXCR4 by SDF-KDEL in SBC-5 cells inhibits their migration in vitro and organ metastasis in vivo.
    Ma N; Pang H; Shen W; Zhang F; Cui Z; Wang J; Wang J; Liu L; Zhang H
    Int J Mol Med; 2015 Feb; 35(2):425-32. PubMed ID: 25504108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of CXCR4 by RNA interference inhibits cell growth and metastasis in human renal cancer cells.
    Wang L; Huang T; Chen W; Gao X; Zhou T; Wu Z; Sun Y
    Oncol Rep; 2012 Dec; 28(6):2043-8. PubMed ID: 22972438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MET receptor is a potential therapeutic target in high grade cervical cancer.
    Miekus K; Pawlowska M; Sekuła M; Drabik G; Madeja Z; Adamek D; Majka M
    Oncotarget; 2015 Apr; 6(12):10086-101. PubMed ID: 25888626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insight into the SDF-1/CXCR4 axis in a breast carcinoma model: hypoxia-induced endothelial SDF-1 and tumor cell CXCR4 are required for tumor cell intravasation.
    Jin F; Brockmeier U; Otterbach F; Metzen E
    Mol Cancer Res; 2012 Aug; 10(8):1021-31. PubMed ID: 22767589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.
    Yadav VN; Zamler D; Baker GJ; Kadiyala P; Erdreich-Epstein A; DeCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
    Oncotarget; 2016 Dec; 7(50):83701-83719. PubMed ID: 27863376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer.
    Kodama J; Hasengaowa ; Kusumoto T; Seki N; Matsuo T; Ojima Y; Nakamura K; Hongo A; Hiramatsu Y
    Ann Oncol; 2007 Jan; 18(1):70-76. PubMed ID: 17032700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
    Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
    Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo.
    Guo F; Tian J; Cui M; Fang M; Yang L
    Mol Med Rep; 2015 Jul; 12(1):753-9. PubMed ID: 25738807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin exhibits anti-tumor effect and attenuates cellular migration via Slit-2 mediated down-regulation of SDF-1 and CXCR4 in endometrial adenocarcinoma cells.
    Sirohi VK; Popli P; Sankhwar P; Kaushal JB; Gupta K; Manohar M; Dwivedi A
    J Nutr Biochem; 2017 Jun; 44():60-70. PubMed ID: 28402926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baohuoside I suppresses invasion of cervical and breast cancer cells through the downregulation of CXCR4 chemokine receptor expression.
    Kim B; Park B
    Biochemistry; 2014 Dec; 53(48):7562-9. PubMed ID: 25407882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development.
    Tan HX; Xiao ZG; Huang T; Fang ZX; Liu Y; Huang ZC
    Cancer Biol Ther; 2020; 21(3):248-257. PubMed ID: 31818187
    [No Abstract]   [Full Text] [Related]  

  • 20. A Lentiviral CXCR4 overexpression and knockdown model in colorectal cancer cell lines reveals plerixafor-dependent suppression of SDF-1α-induced migration and invasion.
    Heckmann D; Laufs S; Maier P; Zucknick M; Giordano FA; Veldwijk MR; Eckstein V; Wenz F; Zeller WJ; Fruehauf S; Allgayer H
    Onkologie; 2011; 34(10):502-8. PubMed ID: 21985848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.